Avalo Therapeutics Q3 EPS $(0.34) Beats $(0.61) Estimate
Benzinga Newsdesk 6 days ago
NewsEarningsEarnings Beats
Avalo Therapeutics (NASDAQ:AVTX) reported quarterly losses of $(0.34) per share which beat the analyst consensus estimate of $(0.61) by 44.26 percent. This is a 84.47 percent increase over losses of $(2.19) per share
Avalo Therapeutics (NASDAQ:AVTX) reported quarterly losses of $(0.34) per share which beat the analyst consensus estimate of $(0.61) by 44.26 percent. This is a 84.47 percent increase over losses of $(2.19) per share from the same period last year.